Mink Therapeutics Stock Forecast

Buy candidate since Jun 09, 2026 Gain 3.64%

The MiNK Therapeutics, Inc. stock price gained 0.91% on the last trading day (Monday, 22nd Jun 2026), rising from $12.14 to $12.25. During the last trading day the stock fluctuated 4.16% from a day low at $12.01 to a day high of $12.51. The price has risen in 6 of the last 10 days and is up by 3.2% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 20 thousand shares were bought and sold for approximately $242.77 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.55% during the next 3 months and, with a 90% probability hold a price between $10.80 and $16.59 at the end of this 3-month period.

INKT Signals & Forecast

The MiNK Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.19 and $11.52. A breakdown below any of these levels will issue sell signals. MiNK Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 17, 2026, and so far it has fallen -13.79%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for MiNK Therapeutics, Inc. stock

MiNK Therapeutics, Inc. finds support from accumulated volume at $12.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.500 between high and low, or 4.16%. For the last week, the stock has had daily average volatility of 6.00%.

Our recommended stop-loss: $11.51 (-6.02%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 44 days ago.)

Trading Expectations (INKT) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect MiNK Therapeutics, Inc. to open at $12.26, and during the day (based on 14 day Average True Range), to move between $11.81 and $12.69, which gives a possible trading interval of +/-$0.87 (+/-7.38%) up or down from last closing price. If MiNK Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.20 (0.41%) than the resistance at $12.34 (0.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MiNK Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for MiNK Therapeutics, Inc. stock to perform well in the short-term.

Current score: 1.108 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $12.26 ( 0.0544%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk